[Wick Erste Abwehr].
D000284:Administration, Oral; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000188:drug therapy / Q000451:nursing* / Q000821:virology; D005782:Gels; D006801:Humans; D065347:Hypromellose Derivatives; D008747:Methylcellulose / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D009092:Mucous Membrane / Q000821:virology; D009305:Nasopharynx / Q000821:virology; D012229:Rhinovirus / Q000187:drug effects* / Q000472:pathogenicity; D014774:Virulence / Q000187:drug effects; D038301:Virus Inactivation / Q000187:drug effects*
D000998:Antiviral Agents; D005782:Gels; D065347:Hypromellose Derivatives; D008747:Methylcellulose